Phoenix Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,281	Closed	-$1.53M	–	405
2021 Q3	$1.53M	Buy	16,281 +508	+3%	+$47.8K	0.03%	233
2021 Q2	$1.53M	Buy	15,773 +5,539	+54%	+$536K	0.03%	230
2021 Q1	$965K	Buy	+10,234	New	+$965K	0.02%	283